The influence of amoeba metal homeostasis on antifungal activity against Cryptococcus gattii

Maria Eduarda Deluca João1, Andrea Gomes Tavanti1, Alexandre Nascimento de Vargas2

  • 1Universidade Federal do Rio Grande do Sul (UFRGS), Centro de Biotecnologia, Programa de Pós-Graduação em Biologia Celular e Molecular, Porto Alegre, RS, Brazil.

PubMed

Insights

Free-living amoebas use nutritional immunity to control fungal pathogens like Cryptococcus. Reducing a specific metal transporter in amoebas enhances fungal growth, revealing a new antifungal defense mechanism.

Area of Science:

  • Microbiology
  • Mycology
  • Parasitology

Background:

  • Free-living amoebas prey on fungi, including pathogenic Cryptococcus species.
  • Cryptococcus requires nutrients, like zinc, for virulence within host cells.
  • Phagocytes limit metal availability as an antifungal defense.

Purpose of the Study:

  • To investigate the role of Acanthamoeba castellanii ACA1_271600 gene in metal homeostasis.
  • To determine the impact of ACA1_271600 on Cryptococcus gattii survival and proliferation.

Main Methods:

  • Gene silencing of ACA1_271600 in A. castellanii.
  • Evaluating Cryptococcus gattii (WT and zip1 mutant) interaction with silenced amoebas.
  • Systems biology analysis.

Main Results:

  • Silencing ACA1_271600 in amoebas increased Cryptococcus proliferation.
  • This effect was more significant with the zinc-impaired Cryptococcus zip1 mutant.
  • Systems biology suggested ACA1_271600 impacts amoebal activity against fungi.

Conclusions:

  • Acanthamoeba castellanii employs nutritional immunity against Cryptococcus.
  • The ACA1_271600 gene product modulates metal availability, influencing fungal survival.
  • This study highlights a novel host-pathogen interaction mechanism.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...